N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in Schizophrenia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This study will evaluate the effect of the dietary supplement N-acetylcysteine (NAC) on electrophysiologic (EEG) markers related to cognition, as well as performance on psychological tests measuring cognition. The primary hypothesis is that participants treated with NAC will show improvements in cognitive function, as measured by EEG and performance-based tests.
Epistemonikos ID: b27be9348dc26ae750e3e6a3818fc165b23425ef
First added on: May 11, 2024